相关实验视频

Updated: Jun 14, 2025

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

针对B7-H家族中的新型免疫检查点:将癌症免疫疗法从长椅推进到床边

Yiming Luo¹, Ye Yuan¹, Dan Liu²

¹Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.

Trends in cancer

|March 20, 2025

概括

免疫检查点分子的B7-H家族通过影响T细胞反应来调节瘤免疫力. 了解这些分子为癌症治疗提供了新的治疗策略.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
分子生物学分子生物学

背景情况:

免疫检查点分子的B7-H家族在瘤内的免疫调节网络中发挥着关键作用.
这些分子,包括B7-H2 (ICOSLG),B7-H3,B7-H4,B7-H5 (VISTA),B7-H6和B7-H7 (HHLA2),在先天性和适应性免疫中表现出各种功能.
它们可以对T细胞产生共刺激或共抑制作用,影响T细胞激活,分化和效应器功能.

研究的目的:

审查B7-H家族成员的结构特征,受体-连接体相互作用和信号通路.
探索B7-H家族对瘤免疫力的影响.
讨论针对B7-H家族的潜在治疗策略.

主要方法:

关于B7-H家族成员的文献综述.
对结构特征和受体-连接体相互作用的分析.
检查信号通路及其在瘤免疫力中的作用.

主要成果:

B7-H家族包括在免疫调节中具有多种作用的分子,影响T细胞反应和免疫细胞招募.
每个B7-H成员具有独特的结构特征,并与特定的受体相互作用,导致不同的信号结果.
B7-H分子的失调与瘤免疫逃避和进展有关.

结论:

B7-H家族代表了癌症免疫治疗的重要目标.
对B7-H相互作用和信号通路的进一步研究可以导致新的治疗干预措施.
调节B7-H家族为增强抗瘤免疫力和克服治疗耐药性提供了一个有希望的方法.

关键词:

B7-H家族家族B7-H家族B7-H家族癌症免疫疗法免疫疗法免疫检查点的检查点.瘤微环境是一个微环境.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...